Literature DB >> 34993580

Serum uric acid levels associated with biochemical parameters linked to preeclampsia severity and to adverse perinatal outcomes.

Elaine Luiza Santos Soares de Mendonça1, João Victor Farias da Silva1, Carolina Santos Mello2, Alane Cabral Menezes de Oliveira3.   

Abstract

AIMS: Evaluating the association between serum uric acid levels and biochemical parameters linked to preeclampsia (PE) severity and to adverse perinatal outcomes.
METHODS: Cross-sectional study. Information about gestational and biochemical parameters were collected before delivery, whereas perinatal outcomes were observed after it. Pregnant women were divided into hyperuricemia-HU (uric acid ≥ 6 mg/dL) or normouricemia (uric acid, 2.6-5.9 mg/dL) groups. Poisson regression models (prevalence ratio-PR; 95% confidence interval-95% CI), multinomial logistic regression (odds ratio-OR; 95% CI), and Pearson's correlation (correlation coefficient-r) were applied by taking into consideration p < 0.05 as significance level.
RESULTS: The total sample comprised 267 pregnant women with PE. HU was observed in 25.8% of patients; it was associated with black pregnant women (p = 0.014) and with primiparity (p = 0.007). Uric acid levels were higher in early PE cases than in late PE cases (p = 0.013); however, there was no significant difference between mild and severe PE cases (p = 0.121). Uric acid recorded a positive correlation to urea (p < 0.001), creatinine (p = 0.002), glutamic-oxaloacetic transaminase (p < 0.001), glutamic-pyruvic transaminase (p = 0.005), ferritin (p = 0.002) and globulin (p = 0.002); as well as negative correlation to platelets (p = 0.035), lactic dehydrogenase (p = 0.039) and albumin (p > 0.001). HU was a factor associated with cesarean delivery (p = 0.030), prematurity (p = 0.001), low birth weight (p < 0.001) and small for gestational age (p = 0.020).
CONCLUSION: High serum uric acid levels were associated with early-onset PE. Maternal features were correlated to biochemical parameters linked to PE severity and to adverse perinatal outcomes.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Hypertension; Hyperuricemia; Premature; Small for gestational age

Mesh:

Substances:

Year:  2022        PMID: 34993580     DOI: 10.1007/s00404-021-06313-2

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  36 in total

Review 1.  Global and regional estimates of preeclampsia and eclampsia: a systematic review.

Authors:  Edgardo Abalos; Cristina Cuesta; Ana L Grosso; Doris Chou; Lale Say
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-06-07       Impact factor: 2.435

2.  Validation of fullPIERS model for prediction of adverse outcomes among women with severe pre-eclampsia.

Authors:  Silvana T Almeida; Leila Katz; Isabela Coutinho; Melania M R Amorim
Journal:  Int J Gynaecol Obstet       Date:  2017-05-23       Impact factor: 3.561

3.  The value of uterine artery Doppler and NT-proBNP levels in the second trimester to predict preeclampsia.

Authors:  İbrahim Uyar; Sefa Kurt; Ömer Demirtaş; Tutku Gurbuz; Onur Suleyman Aldemir; Buket Keser; Abdullah Tasyurt
Journal:  Arch Gynecol Obstet       Date:  2014-12-06       Impact factor: 2.344

Review 4.  Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice.

Authors:  Mark A Brown; Laura A Magee; Louise C Kenny; S Ananth Karumanchi; Fergus P McCarthy; Shigeru Saito; David R Hall; Charlotte E Warren; Gloria Adoyi; Salisu Ishaku
Journal:  Hypertension       Date:  2018-07       Impact factor: 10.190

Review 5.  Prediction of preeclampsia developing at term.

Authors:  Iulia Huluta; Anca Maria Panaitescu
Journal:  Ginekol Pol       Date:  2018       Impact factor: 1.232

6.  Uric acid induces trophoblast IL-1β production via the inflammasome: implications for the pathogenesis of preeclampsia.

Authors:  Melissa J Mulla; Kledia Myrtolli; Julie Potter; Crina Boeras; Paula B Kavathas; Anna K Sfakianaki; Serkelem Tadesse; Errol R Norwitz; Seth Guller; Vikki M Abrahams
Journal:  Am J Reprod Immunol       Date:  2011-06       Impact factor: 3.886

7.  Maternal serum uric acid and calcium as predictors of hypertensive disorder of pregnancy: A case control study.

Authors:  Naina Kumar; Amit Kant Singh
Journal:  Taiwan J Obstet Gynecol       Date:  2019-03       Impact factor: 1.705

8.  Prediction models for preeclampsia: A systematic review.

Authors:  Annelien C De Kat; Jane Hirst; Mark Woodward; Stephen Kennedy; Sanne A Peters
Journal:  Pregnancy Hypertens       Date:  2019-03-11       Impact factor: 2.899

9.  Deaths from total and premature cardiovascular disease associated with high normal blood pressure and hypertension in rural Chinese men and elderly people.

Authors:  Leilei Liu; Yu Liu; Yongcheng Ren; Yang Zhao; Pei Qin; Dechen Liu; Xu Chen; Cheng Cheng; Feiyan Liu; Chunmei Guo; Qionggui Zhou; Quanman Li; Gang Tian; Minghui Han; Ranran Qie; Xiaoyan Wu; Shengbing Huang; Xinping Luo; Ruirong Cheng; Dongsheng Hu; Jian Wang; Ming Zhang
Journal:  J Hum Hypertens       Date:  2020-07-20       Impact factor: 3.012

10.  Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study.

Authors:  Evelyn A Huhn; Ina Hoffmann; Begoña Martinez De Tejada; Soeren Lange; Kylie M Sage; Charles T Roberts; Michael G Gravett; Srinivasa R Nagalla; Olav Lapaire
Journal:  BMC Pregnancy Childbirth       Date:  2020-02-24       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.